Dosing and Misuse of Buprenorphine in the New Jersey Department of Corrections.
addiction
buprenorphine
correctional psychiatry
diversion
dosing
opioid use disorder
Journal
The journal of the American Academy of Psychiatry and the Law
ISSN: 1943-3662
Titre abrégé: J Am Acad Psychiatry Law
Pays: United States
ID NLM: 9708963
Informations de publication
Date de publication:
12 Sep 2024
12 Sep 2024
Historique:
medline:
13
9
2024
pubmed:
13
9
2024
entrez:
12
9
2024
Statut:
aheadofprint
Résumé
Opioid use disorder is common in incarcerated persons, and concern about the diversion of buprenorphine is a barrier to treatment. We conducted a retrospective chart review of incarcerated persons in the New Jersey Department of Corrections who received charges for misuse of medication, including buprenorphine, hypothesizing that the prescription of buprenorphine monoproduct, multiple tabs or films of buprenorphine, or higher doses of buprenorphine would be associated with more diversion incidents. Within the dosing range of 2 to 12 mg, there were more incidents of diversion of buprenorphine monoproduct (24.3%) compared with buprenorphine-naloxone (10.7%,
Identifiants
pubmed: 39266241
pii: JAAPL.240071-24
doi: 10.29158/JAAPL.240071-24
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024 American Academy of Psychiatry and the Law.